Laparoscopic Adjustable Gastric Banding: a Prospective Randomized Clinical Trial Comparing 5-Year Results of two Different Bands in 103 Patients

Juodeikis, Žygimantas; Abalikšta, Tomas; Brimienė, Vilma; Brimas, Gintautas

doi:10.1007/s11695-016-2416-5

Cited by 3 publications

(2 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All patients underwent a standard LAGB using the pars flaccida technique, which was described earlier [ 10 ]. Patients were repeatedly evaluated 1 and 4 years postoperatively.…”

Section: Methodsmentioning

confidence: 99%

A prospective 4-year study of insulin resistance and adipokines in morbidly obese diabetic and non-diabetic patients after gastric banding.

Urbanavičius

Juodeikis

Dženkevičiūtė

et al. 2017

Videosurgery and Other Miniinvasive Techniques

Self Cite

View full text Add to dashboard Cite

IntroductionThere are insufficient data regarding the changes in adipokine levels after laparoscopic adjustable gastric banding (LAGB) in diabetic and non-diabetic patients and their effects on insulin resistance and type 2 diabetes remission.AimTo assess leptin, adiponectin, and insulin resistance changes after LAGB in diabetic and non-diabetic morbidly obese patients.Material and methodsOne hundred and three patients (37 with and 66 without type 2 diabetes) underwent LAGB from January 2009 to January 2010. Glycated hemoglobin, insulin, adipokine levels and insulin resistance were evaluated preoperatively, and 1 and 4 years after LAGB.ResultsThe mean patient age was 45.9 ±11.7 years and mean preoperative body mass index was 47.5 ±7.3 kg/m2. A total of 80 of 103 patients (77.6%) completed the 4-year follow-up. After 4 years the mean excess weight loss was 38.8% and 39.5% in diabetic and non-diabetic patients respectively. Leptin levels decreased significantly in both groups at 1 year, but after 4 years this was noted only in non-diabetic patients. After 1 year adiponectin levels increased significantly only in non-diabetic patients (p = 0.003) and remained almost the same at 4 years. A significant decrease in insulin resistance was noted in both groups 1 year after LAGB and diabetes remission was observed in 23 (62.1%) patients. There was a negative correlation between preoperative insulin resistance and adiponectin levels throughout the follow-up period. Leptin levels positively correlated with BMI throughout the study period (baseline r = 0.45; p < 0.001; after 1 year r = 0.71; p < 0.001; after 4 years r = 0.68; p < 0.001). There was no significant correlation between leptin and adiponectin concentrations preoperatively or after 1 year; however, at 4 years it was significant (r = 0.27; p < 0.02).ConclusionsThe most significant metabolic changes occurred within 1 year after LAGB. The 4-year follow-up revealed stabilization in metabolic indices rather than significant improvement.

show abstract

“…All patients underwent a standard LAGB using the pars flaccida technique, which was described earlier [ 10 ]. Patients were repeatedly evaluated 1 and 4 years postoperatively.…”

Section: Methodsmentioning

confidence: 99%

A prospective 4-year study of insulin resistance and adipokines in morbidly obese diabetic and non-diabetic patients after gastric banding.

Urbanavičius

Juodeikis

Dženkevičiūtė

et al. 2017

Videosurgery and Other Miniinvasive Techniques

Self Cite

View full text Add to dashboard Cite

show abstract

“…Between January 1, 2009 and January 31, 2010, 103 morbidly obese patients (64 NSO and 39 SO patients) underwent LAGB at the Vilnius University Hospital ‘Santariškių Klinikos’. All patients underwent a standard LAGB using the pars flaccida technique, which has been described previously [9]. A single surgeon performed all of the operations.…”

Section: Methodsmentioning

confidence: 99%

A prospective study comparing 5-year results between superobese and non-superobese patients after laparoscopic adjustable gastric banding.

Juodeikis

Brimienė

Brimas

2018

Videosurgery and Other Miniinvasive Techniques

Self Cite

View full text Add to dashboard Cite

IntroductionLaparoscopic adjustable gastric banding (LAGB) is considered to be the least invasive, reversible, and the safest bariatric operation regarding mortality and morbidity, and its application to high-risk superobese (SO) individuals seems rational.AimThere are differing viewpoints regarding the effectiveness of LAGB in superobese (BMI > 50 kg/m2) patients. The aim of this study was to compare the safety and efficacy of LAGB in SO and non-superobese (NSO) patients in the long term (> 5 years).Material and methodsWe undertook a prospective single-center study to compare the safety and efficacy of LAGB in SO and NSO patients after 5 years. One hundred and three morbidly obese patients underwent LAGB in the period from January 2009 to January 2010. Sixty-four of the patients were NSO and 39 SO. After 5 years, we evaluated their weight loss, comorbidities, complications, and quality of life.ResultsA total of 90 of 103 patients (87.3%) completed the 5-year follow-up. The percentage excess weight loss was 50.4% in the NSO and 38.8% in the SO group (p = 0.072). The proportion of patients who lost > 50% excess weight was significantly larger in the NSO group (p = 0.045). There were significantly more patients in the NSO group whose metabolic syndrome had resolved (p < 0.001). There were no differences regarding the resolution of other comorbidities and postoperative complications.ConclusionsThis study suggests that LAGB can lead to substantial and long-lasting weight loss after 5 years. Our study found that SO patients demonstrate inferior weight loss results, and lower overall BAROS scores; thus we do not support the primary use of LAGB in SO patients.

show abstract

Foregut Erosion Related to Biomedical Implants: A Scoping Review

Aiolfi,

Sozzi,

Bonitta

et al. 2024

Journal of Laparoendoscopic & Advanced Surgical Techniques

View full text Add to dashboard Cite

Laparoscopic Adjustable Gastric Banding: a Prospective Randomized Clinical Trial Comparing 5-Year Results of two Different Bands in 103 Patients

Abstract: SAGB and MiniMizer Extra bands demonstrated similar long-term results regarding the weight loss, resolution of comorbidities, morbidity, and quality of life.

Cited by 3 publications

References 20 publications

A prospective 4-year study of insulin resistance and adipokines in morbidly obese diabetic and non-diabetic patients after gastric banding.

A prospective 4-year study of insulin resistance and adipokines in morbidly obese diabetic and non-diabetic patients after gastric banding.

A prospective study comparing 5-year results between superobese and non-superobese patients after laparoscopic adjustable gastric banding.

Foregut Erosion Related to Biomedical Implants: A Scoping Review

Contact Info

Product

Resources

About